Michael Davis’ heart surgery was hours behind schedule. The 71-year-old South Florida retiree waited and waited and waited ...
Transmural Systems, a leader in pioneering electrosurgical structural heart therapies, obtained 510(k) clearance from the United States Food and Drug Administration (FDA) for TELLTALE -- the first and ...
Stepping back into competitive sports after heart surgery sounds understandable, but for these athletes, it’s just part of ...
Invasive epicardial coronary physiologic assessment is increasingly performed to evaluate the hemodynamic significance of ...
Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...
Additionally, several new trials reporting longer-term follow-up on MICS coronary and valve surgery have demonstrated durable ...
After waiting nearly eight hours for his heart surgery to be performed, his UM surgeon canceled the procedure at the last moment.
Another finding the researchers report from their experiments is that microplastics triggered harmful gene activity in both mouse and human endothelial cells. Exposure to microplastics was found to ...
Caranx Medical ("Caranx"), a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving ...
JenaValve today announced the completion of the 1,000th commercial procedure using its Trilogy transcatheter heart valve (THV ...
JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the completion of its 1,000th commercial Trilogy procedure, performed in ...
The global PARADIGM Trial (ClinicalTrials.gov ID NCT07194265) is a prospective, randomized controlled trial (RCT) which will evaluate the safety and effectiveness of the DurAVR ® THV compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback